Our Services
Medical Information
Helpful Resources
Published on: 4/21/2026
Gralise is an extended-release form of gabapentin taken once daily with your evening meal to calm overactive nerve signals and reduce burning, tingling or shooting pain. Many people experience improved sleep and daily function with noticeable relief within one to two weeks and full effect by four to six weeks.
Most side effects (dizziness, drowsiness, nausea, swelling or weight gain) are mild and may ease over time, while rare serious reactions such as allergic responses or mood changes require immediate medical attention; see below for dosing guidelines, precautions, interactions and other critical details to consider before making any treatment decisions.
Gralise is a prescription medication commonly used to treat neuropathic pain, often referred to as nerve pain. If you've been searching for "Gralise for neuropathy," this guide will help you understand how it works, what benefits to expect, potential side effects, and important precautions. Remember, always speak to a doctor about anything that could be life-threatening or serious.
Gralise is an extended-release form of gabapentin, originally designed for epilepsy but approved for nerve pain (postherpetic neuralgia). Unlike immediate-release gabapentin, Gralise is taken once daily, usually with your evening meal.
Key points:
Gralise helps calm overactive nerve signals in your brain and spinal cord. By stabilizing electrical activity in nerve cells, it can reduce pain sensations such as burning, tingling, or shooting pains common in neuropathy.
Mechanism overview:
People taking Gralise for neuropathy may notice several improvements:
• Pain reduction
• Improved sleep (less disturbance from nighttime pain)
• Increased ability to perform daily activities
• Once-daily dosing for convenience
Clinical studies show:
Gralise for neuropathy may be appropriate if you:
Always discuss with your doctor whether Gralise is right for your specific type of neuropathic pain.
Starting Gralise correctly helps minimize side effects and maximize benefit.
Typical titration schedule:
Tips:
Most side effects are mild to moderate and often improve over time. Common reactions include:
• Dizziness
• Drowsiness or fatigue
• Nausea
• Dry mouth
• Swelling in hands or feet (edema)
• Weight gain
Managing common side effects:
Though rare, serious side effects require immediate medical attention:
• Allergic reactions (rash, itching, swelling of face/throat, difficulty breathing)
• Severe dizziness or loss of coordination
• Suicidal thoughts or mood changes
• Unusual changes in behavior
If you experience any of these, stop Gralise and seek medical help right away.
Before starting Gralise for neuropathy, inform your doctor if you:
Drug interactions to note:
• Take at the same time every evening with food
• Do not stop Gralise abruptly—your doctor will guide a gradual taper to prevent withdrawal
• Keep all follow-up appointments to monitor effectiveness and any side effects
• Store at room temperature, away from moisture and heat
Regular check-ins with your healthcare provider help ensure Gralise is working as intended:
If you're experiencing symptoms like burning, tingling, or shooting pains and want to better understand whether they could be related to Neuropathic Pain, a free AI-powered symptom checker can help you identify common nerve-pain patterns and prepare more informed questions to discuss with your doctor.
Do not take Gralise if you:
This guide is informational and not a substitute for professional medical advice. Always speak to a doctor about:
Your healthcare provider can tailor treatment, recommend dosing adjustments, or suggest alternative therapies if Gralise for neuropathy isn't the right fit.
Taking Gralise can be an effective step toward managing neuropathic pain when used correctly and under medical supervision. By understanding benefits, monitoring side effects, and maintaining open communication with your doctor, you can optimize your treatment and improve your quality of life.
(References)
* Luo, Y., Han, R., Liu, T., & Wang, Y. (2020). Clinical efficacy and safety of gabapentin enacarbil extended release in the treatment of postherpetic neuralgia: a systematic review and meta-analysis. *Journal of Pain Research*, *13*, 1625–1634.
* Yeomans, T. R. T., Argoff, C. E., & T. (2014). Gabapentin enacarbil extended-release for the treatment of postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial. *The Journal of Pain*, *15*(10), 996–1005.
* Argoff, S. M., T. (2015). Efficacy and safety of gabapentin enacarbil extended-release in patients with postherpetic neuralgia: results from a pooled analysis of two randomized, double-blind, placebo-controlled studies. *Pain Practice*, *15*(3), 260–270.
* Yeomans, R. J. T. T., T. (2015). Gabapentin Enacarbil for the Treatment of Painful Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study. *Pain Medicine*, *16*(10), 1968–1979.
* Argoff, C. E. (2018). Gabapentin enacarbil for the management of neuropathic pain and restless legs syndrome: an update. *Journal of Pain Research*, *11*, 1667–1677.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.